Post Time: 2025-02-18
Error: No content files found.To learn more about the top medical innovations for 2022, please visit In the United States, 1 in 10 individuals has diabetes, which affects how the body processes food into energy. One potential therapy is a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1) that aims to simply click the up coming internet page control blood sugar. Injected under the skin, GLP-1 and GIP receptors cause the pancreas to release insulin and block the hormone glucagon, limiting blood sugar spikes after a meal. Additionally, why not look here it slows digestion, resulting in individuals remaining full longer and eating less. Thus far, More about the author late phase III clinical trials reveal that the treatment significantly reduces hemoglobin A1C in type 2 diabetes and supports weight loss, making it potentially the most effective therapy for diabetes and obesity yet developed. ▶Share this video with others: ▶Subscribe to learn more about Cleveland Clinic: #ClevelandClinic #MedicalInnovations